Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer.
Henricks J, Haddad T, Ahmed O, Schoenhals J, Kumar P, Wilson R, Ma J, Wang JG, Wert M, Esguerra V, Bentley I, Johnson K, Stover D, Jhawar SR, Gatti-Mays M, Ho K.
Henricks J, et al. Among authors: ahmed o.
Breast Cancer Res. 2025 Feb 3;27(1):16. doi: 10.1186/s13058-025-01967-1.
Breast Cancer Res. 2025.
PMID: 39901280